Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Kristina Gemzell-Danielsson, Angelo Cagnacci, Nathalie Chabbert-Buffet, Jonathan Douxfils, Jean-Michel Foidart, Ali Kubba, Luis Ignacio Lete Lasa, Diana Mansour, Joseph Neulen, Jaoquim Neves, Fátima Palma, Thomas Römer, Robert Spaczyński & Vera Tóth. (2022) A novel estetrol-containing combined oral contraceptive: European expert panel review. The European Journal of Contraception & Reproductive Health Care 27:5, pages 373-383.
Read now
Read now
Suzanne Reed, Carol Koro, Julia DiBello, Kerstin Becker, Anja Bauerfeind, Christian Franke & Klaas Heinemann. (2021) Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism. The European Journal of Contraception & Reproductive Health Care 26:6, pages 439-446.
Read now
Read now
Santiago Palacios, Enrico Colli & Pedro A. Regidor. (2021) Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study. The European Journal of Contraception & Reproductive Health Care 26:6, pages 454-461.
Read now
Read now
Iñaki Lete. (2021) Combined hormonal contraception and COVID-19. The European Journal of Contraception & Reproductive Health Care 26:2, pages 128-131.
Read now
Read now
Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Read now
Giovanni Grandi, Fabio Barra, Simone Ferrero & Fabio Facchinetti. (2019) Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism 14:3, pages 153-155.
Read now
Read now
Angelo Cagnacci, Carlo Bastianelli, Manuela Neri, Antonio Cianci, Chiara Benedetto, Luana Calanni, Michele Vignali, Vincenzo De Leo, Ettore Cicinelli, Giuseppe Borrelli & Annibale Volpe. (2018) Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO). The European Journal of Contraception & Reproductive Health Care 23:6, pages 393-399.
Read now
Read now
Manuela Neri, Maria Elena Malune, Valentina Corda, Bruno Piras, Pierina Zedda, Monica Pilloni, Maria Paola Orani, Valerio Vallerino, Gian Benedetto Melis & Anna Maria Paoletti. (2017) Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC). Gynecological Endocrinology 33:12, pages 958-962.
Read now
Read now
Manuela Farris, Carlo Bastianelli, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis. Expert Review of Clinical Pharmacology 10:10, pages 1129-1144.
Read now
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2017) Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?. The European Journal of Contraception & Reproductive Health Care 22:4, pages 245-246.
Read now
Read now
Giovanni Grandi, Antonella Napolitano & Angelo Cagnacci. (2016) Metabolic impact of combined hormonal contraceptives containing estradiol. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 779-787.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Articles from other publishers (15)
Alessandra Graziottin, Angela Cuccarollo, Massimo P. Franchi & Stefano Uccella. (2022) Patologie mestruali e contraccezione: principi di personalizzazione della scelta terapeutica. L'Endocrinologo.
Crossref
Crossref
I. Lete. (2022) Evolución del estrógeno en la anticoncepción hormonal combinada: del etinilestradiol al estetrol pasando por el estradiol. Clínica e Investigación en Ginecología y Obstetricia 49:3, pages 100755.
Crossref
Crossref
İlkin Seda CAN. (2022) EVALUATION OF CONTRACEPTIVE METHOD USAGE CHANGES AND SATISFACTION OF WOMEN DURING THE COVID-19 PANDEMICCovid-19 Pandemisi Sırasında Kadınların Kontraseptif Yöntem Kullanım Değişimlerinin ve Memnuniyetlerinin Değerlendirilmesi. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 24:1, pages 118-127.
Crossref
Crossref
Rossella Nappi, Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco & Cristina Tassorelli. (2022) Role of Estrogens in Menstrual Migraine. Cells 11:8, pages 1355.
Crossref
Crossref
Thierry Habyarimana, Callixte Yadufashije, Vestine Mukantwali, Alexis Nshimiyinana, Francois Niyonzima, Clementine Yamukujije & Joseph Mucumbitsi. (2022) Association between hormonal contraceptive use and derangement of lipid profile among women attending Muhoza Health Center, Rwanda. Sahel Medical Journal 25:2, pages 47.
Crossref
Crossref
Nelleke van der Weerd, Hine J. A. van Os, Mariam Ali, Jan W. Schoones, Arn M. J. M. van den Maagdenberg, Nyika D. Kruyt, Bob Siegerink & Marieke J. H. Wermer. (2021) Sex Differences in Hemostatic Factors in Patients With Ischemic Stroke and the Relation With Migraine—A Systematic Review. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Gerda Venter, Carien L. van der Berg, Francois H. van der Westhuizen & Elardus Erasmus. (2021) Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol. International Journal of Environmental Research and Public Health 18:20, pages 10607.
Crossref
Crossref
T.F. Tatarchuk, Z.M. Dubossarska, V.I. Pyrohova, N.Y. Pedachenko, T.M. Tutchenko, O.О. Yefimenko, N.V. Kosei, Y.O. Dubossarska, K.L. Shatylovych, V.M. Zaporozhan, V.V. Kaminskyi, G.V. Zaichenko, S.A. Dubrov & L.M. Chernukha. (2021) On the use of sex steroids in women during the COVID-19 pandemic. REPRODUCTIVE ENDOCRINOLOGY:58, pages 9-16.
Crossref
Crossref
Angelo Cagnacci & Anna Biasioli. 2021. Female and Male Contraception. Female and Male Contraception
299
317
.
Jonathan Douxfils, Laure Morimont & Céline Bouvy. (2020) Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Seminars in Thrombosis and Hemostasis 46:08, pages 872-886.
Crossref
Crossref
Anne Gompel, Olivier Fain, Isabelle Boccon-Gibod, Delphine Gobert & Laurence Bouillet. (2020) Exogenous hormones and hereditary angioedema. International Immunopharmacology 78, pages 106080.
Crossref
Crossref
P. Leusink. 2020. Urogynaecologie. Urogynaecologie
91
103
.
. (2019) FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception. BMJ Sexual & Reproductive Health 45:Suppl 1, pages 1-93.
Crossref
Crossref
Roshni Kakaiya, Lia L. Lopez & Anita L. Nelson. (2017) Women’s perceptions of contraceptive efficacy and safety. Contraception and Reproductive Medicine 2:1.
Crossref
Crossref
Nicolás Mendoza, Esperanza Soto & Rafael Sánchez-Borrego. (2016) Do women aged over 40 need different counseling on combined hormonal contraception?. Maturitas 87, pages 79-83.
Crossref
Crossref